154 related articles for article (PubMed ID: 2945697)
21. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
22. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.
Kazatchkine MD; Fearon DT; Appay MD; Mandet C; Bariety J
J Clin Invest; 1982 Apr; 69(4):900-12. PubMed ID: 7042757
[TBL] [Abstract][Full Text] [Related]
24. CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients.
Teixeira JE; Costa RS; Lachmann PJ; Würzner R; Barbosa JE
Clin Exp Immunol; 1996 Sep; 105(3):497-503. PubMed ID: 8809140
[TBL] [Abstract][Full Text] [Related]
25. Immune complex clearance by complement receptor type 1 in SLE.
Kavai M
Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
[TBL] [Abstract][Full Text] [Related]
26. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ
Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783
[TBL] [Abstract][Full Text] [Related]
27. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
Walport MJ; Ross GD; Mackworth-Young C; Watson JV; Hogg N; Lachmann PJ
Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus.
Cohen JH; Caudwell V; Levi-Strauss M; Bourgeois P; Kazatchkine MD
Arthritis Rheum; 1989 Apr; 32(4):393-7. PubMed ID: 2565113
[TBL] [Abstract][Full Text] [Related]
29. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.
Birmingham DJ; Chen W; Liang G; Schmitt HC; Gavit K; Nagaraja HN
Immunology; 2003 Apr; 108(4):531-8. PubMed ID: 12667215
[TBL] [Abstract][Full Text] [Related]
30. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
Said PB; Sarano J; Manni JA; Casellas AM
Medicina (B Aires); 1990; 50(1):21-4. PubMed ID: 2149869
[TBL] [Abstract][Full Text] [Related]
31. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.
Mitchell JA; Sim RB; Sim E
Clin Exp Immunol; 1989 Dec; 78(3):354-8. PubMed ID: 2575471
[TBL] [Abstract][Full Text] [Related]
32. C3b receptor (CR1) on erythrocytes in various diseases.
Takemura S; Deguchi M; Ueda M; Yoshida N; Kato H; Yoshikawa T; Sugino S; Kondo M
Immunol Lett; 1984; 7(6):325-8. PubMed ID: 6233222
[TBL] [Abstract][Full Text] [Related]
33. An immunoradiometric assay for erythrocyte complement (C3b) receptor activity applied to a pediatric population with connective tissue disease.
Buffone GJ; Leatherwood CM; Person DA; Brewer EJ
Clin Chem; 1983 Oct; 29(10):1720-3. PubMed ID: 6616816
[TBL] [Abstract][Full Text] [Related]
34. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
[TBL] [Abstract][Full Text] [Related]
35. Correlative expression of C3b receptors in the glomerulus and on erythrocytes.
Minota S; Terai C; Nojima Y; Takano K; Yamada A; Miyakawa Y; Takaku F
Clin Immunol Immunopathol; 1986 Jan; 38(1):85-92. PubMed ID: 2934197
[TBL] [Abstract][Full Text] [Related]
36. No quantitative relationship between CR1 and Lutheran expression on erythrocytes: In(Lu) gene product is not a common regulator of CR1 expression on erythrocytes.
Oudin S; Lepennec PY; Dervillez X; Tonye-Libyh M; Tabary T; Philbert F; Bougy F; Reveil B; Pennaforte JL; Rouger P; Cohen JH
Exp Clin Immunogenet; 1999; 16(2):72-80. PubMed ID: 10343158
[TBL] [Abstract][Full Text] [Related]
37. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM
Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
[TBL] [Abstract][Full Text] [Related]
38. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L
Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768
[TBL] [Abstract][Full Text] [Related]
39. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
[TBL] [Abstract][Full Text] [Related]
40. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
